Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Fusion Pharmaceuticals Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +2 vs. Q2 2021
- Shares held
- 27.9M
- +4.04M (+17.0%) vs. Q2 2021
- Total value
- $220.6M
- +$28.5M (+14.8%) vs. Q2 2021
- New holders
- 6
- 13 more added
- Sold out
- 4
- 9 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 114 | $1.47B |
| Q4 2023 | 77 | $584.1M |
| Q3 2023 | 41 | $129.8M |
| Q2 2023 | 41 | $235.1M |
| Q1 2023 | 38 | $171.9M |
| Q4 2022 | 30 | $88.9M |
| Q3 2022 | 34 | $80.3M |
| Q2 2022 | 31 | $69.4M |
| Q1 2022 | 28 | $219.1M |
| Q4 2021 | 32 | $116.0M |
| Q3 2021 | 40 | $220.6M |
| Q2 2021 | 39 | $221.8M |
| Q1 2021 | 38 | $295.9M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cutler Group LP | 100 | $0 | 0.00% | +100 | New |
| American Portfolios Advisors | 30 | $238 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 78 | $1.00K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 300 | $2.00K | 0.00% | 00.0% | Unchanged |
| Point72 Hong Kong Ltd | 240 | $2.00K | 0.00% | 00.0% | Unchanged |
| Penserra Capital Management LLC | 980 | $7.00K | 0.00% | +15+1.6% | Added |
| Bank of America Corp | 1,401 | $11.0K | 0.00% | −924−39.7% | Reduced |
| Simplex Trading, LLC | 1,460 | $11.0K | 0.00% | +152+11.6% | Added |
| Bank Julius Baer & Co. Ltd, Zurich | 2,000 | $16.0K | 0.00% | +20+1.0% | Added |
| Citigroup Inc | 2,414 | $19.0K | 0.00% | −160−6.2% | Reduced |
| Royal Bank of Canada | 2,350 | $19.0K | 0.00% | +1,200+104.3% | Added |
| Tower Research Capital LLC (TRC) | 2,654 | $21.0K | 0.00% | −361−12.0% | Reduced |
| JPMorgan Chase & Co | 2,991 | $24.0K | 0.00% | +948+46.4% | Added |
| UBS Group AG | 4,298 | $35.0K | 0.00% | +473+12.4% | Added |
| DekaBank Deutsche Girozentrale | 13,000 | $105.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 20,149 | $160.0K | 0.00% | +1,928+10.6% | Added |
| Geode Capital Management, LLC | 25,136 | $199.0K | 0.00% | +2,047+8.9% | Added |
| Millennium Management LLC | 26,925 | $213.0K | 0.00% | +26,925 | New |
| Sectoral Asset Management Inc | 38,198 | $303.0K | 0.03% | +38,198 | New |
| Tekla Capital Management LLC | 43,394 | $344.0K | 0.01% | +43,394 | New |
| AlphaCentric Advisors LLC | 71,500 | $566.0K | 0.14% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 78,066 | $618.0K | 0.04% | +78,066 | New |
| Morgan Stanley | 82,286 | $651.0K | 0.00% | +6,074+8.0% | Added |
| Woodline Partners LP | 154,621 | $1.23M | 0.02% | +240.0% | Added |
| Sio Capital Management, LLC | 259,763 | $2.06M | 0.66% | −6,344−2.4% | Reduced |
| Victory Capital Management Inc | 267,703 | $2.12M | 0.00% | −1,920−0.7% | Reduced |
| BlackRock Inc. | 414,256 | $3.28M | 0.00% | −56,047−11.9% | Reduced |
| 1832 Asset Management L.P. | 734,321 | $5.84M | 0.01% | 00.0% | Unchanged |
| Artal Group S.A. | 750,000 | $5.94M | 0.15% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 858,012 | $6.79M | 0.03% | −17,129−2.0% | Reduced |
| Rock Springs Capital Management LP | 948,327 | $7.51M | 0.16% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 1,254,607 | $9.94M | 0.14% | −520,560−29.3% | Reduced |
| Federated Hermes, Inc. | 1,453,890 | $11.5M | 0.02% | +856,049+143.2% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,598,379 | $12.7M | 4.47% | +20.0% | Added |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $20.2M | 0.20% | 00.0% | Unchanged |
| Adams Street Partners LLC | 2,947,809 | $23.3M | 3.00% | −25,935−0.9% | Reduced |
| Canada Pension Plan Investment Board | 3,116,966 | $24.7M | 0.03% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,224,770 | $25.5M | 0.28% | 00.0% | Unchanged |
| FMR LLC | 3,226,471 | $25.6M | 0.00% | +42,262+1.3% | Added |
| Johnson & Johnson | 3,670,516 | $29.1M | 2.55% | +3,670,516 | New |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −14,180−100.0% | Sold out |
| Altfest L J & Co Inc | 0 | $0 | 0.00% | −10,213−100.0% | Sold out |
| Paragon Wealth Strategies, LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Johnson & Johnson Innovation - JJDC, Inc. | – | – | – | – | Not filed |